LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

Home・Aandelen Lijst・Novavax Inc

Novavax Inc

Open

SectorGezondheidszorg

9.78 -2.3

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.5

Max

10.01

Belangrijke statistieken
By Trading Economics
Inkomsten	220M 18M
Verkoop	77M 147M
K/W Sectorgemiddelde	5.03 66.845
EPS	0.11
Winstmarge	11.912
Werknemers	952
EBITDA	217M 26M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+33.51% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	122M 1.6B
Vorige openingsprijs	12.08
Vorige sluitingsprijs	9.78

Nieuwssentiment

By Acuity

93%

6 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

5.692 / 6.039 Steun & Weerstand

Novavax Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 apr 2025, 17:06 UTC

Belangrijke Marktbewegers

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mrt 2025, 14:19 UTC

Belangrijke Marktbewegers

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

19 mei 2025, 14:30 UTC

Top Nieuws

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19 mei 2025, 13:27 UTC

Top Nieuws

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8 mei 2025, 17:55 UTC

Winsten

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8 mei 2025, 15:12 UTC

Winsten

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28 apr 2025, 17:04 UTC

Winsten

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

Peer Vergelijking

Prijswijziging

Novavax Inc Prognose

Koersdoel

By TipRanks

33.51% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12.67 USD 33.51%

Hoogste 19 USD

Laagste 7 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Novavax Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Novavax Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.692 / 6.039Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Sentiment

By Acuity

6 / 351 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.